Megan J Huchko1, Hannah Leslie, May Maloba, Jennifer Zakaras, Elizabeth Bukusi, Craig R Cohen. 1. *Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA; †Department of Epidemiology, University of California, Berkeley, CA; and ‡Center for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Abstract
INTRODUCTION: HIV-infected women may have higher rates of recurrent cervical precancer after treatment. Knowledge about rates and predictors of recurrence could impact guidelines and program planning, especially in low-resource settings. METHODS: In this prospective cohort study in Western Kenya, we followed HIV-infected women at 6 and 12 months after treatment for cervical intraepithelial neoplasia 2 or greater (CIN2+) after treatment with loop electrosurgical excision procedure (LEEP). All women underwent follow-up colposcopy with biopsy as indicated for the diagnosis of CIN2+. We calculated the incidence and predictors of primary disease recurrence after treatment. RESULTS: Among the 284 women who underwent LEEP and had at least 1 follow-up visit, there were 37 (13%) cases of CIN2+ detected by 12-month follow-up. Four (10.8%) of the recurrences were invasive cancer, all stage IA1. The 6- and 12-month rates of recurrence were 13.7 and 12.8 cases per 100 person-years of follow-up, respectively. Antiretroviral therapy use did not significantly impact the rate of recurrence (hazard ratio: 1.24, 95% confidence interval: 0.59 to 2.79). The only significant predictor of recurrence in the multivariate analysis was CD4(+) nadir <200 cells per cubic millimeter (adjusted hazard ratio: 3.14, 95% confidence interval: 1.22 to 8.08). DISCUSSION: The overall rate of treatment failure within a year of LEEP was low in this cohort of HIV-infected women. Among the women with recurrence, there was a significant amount of invasive cancer. The relatively high rate of cancer after treatment suggests that HIV-infected women merit continued close follow-up after treatment.
INTRODUCTION:HIV-infectedwomen may have higher rates of recurrent cervical precancer after treatment. Knowledge about rates and predictors of recurrence could impact guidelines and program planning, especially in low-resource settings. METHODS: In this prospective cohort study in Western Kenya, we followed HIV-infectedwomen at 6 and 12 months after treatment for cervical intraepithelial neoplasia 2 or greater (CIN2+) after treatment with loop electrosurgical excision procedure (LEEP). All women underwent follow-up colposcopy with biopsy as indicated for the diagnosis of CIN2+. We calculated the incidence and predictors of primary disease recurrence after treatment. RESULTS: Among the 284 women who underwent LEEP and had at least 1 follow-up visit, there were 37 (13%) cases of CIN2+ detected by 12-month follow-up. Four (10.8%) of the recurrences were invasive cancer, all stage IA1. The 6- and 12-month rates of recurrence were 13.7 and 12.8 cases per 100 person-years of follow-up, respectively. Antiretroviral therapy use did not significantly impact the rate of recurrence (hazard ratio: 1.24, 95% confidence interval: 0.59 to 2.79). The only significant predictor of recurrence in the multivariate analysis was CD4(+) nadir <200 cells per cubic millimeter (adjusted hazard ratio: 3.14, 95% confidence interval: 1.22 to 8.08). DISCUSSION: The overall rate of treatment failure within a year of LEEP was low in this cohort of HIV-infectedwomen. Among the women with recurrence, there was a significant amount of invasive cancer. The relatively high rate of cancer after treatment suggests that HIV-infectedwomen merit continued close follow-up after treatment.
Authors: Kevin P McKenzie; Robyn K Rogers; Julia W Njoroge; Grace John-Stewart; Barbra A Richardson; Nelly R Mugo; Hugo De Vuyst; Ritesh N Pamnani; Farzana S Rana; Danson Warui; Michael H Chung Journal: Curr HIV Res Date: 2011-04 Impact factor: 1.581
Authors: Maria Inês Lima; Alexandre Tafuri; Angela C Araújo; Luiza de Miranda Lima; Victor Hugo Melo Journal: Int J Gynaecol Obstet Date: 2008-12-05 Impact factor: 3.561
Authors: Cynthia Firnhaber; Daniel Westreich; Doreen Schulze; Sophie Williams; Maureen Siminya; Pam Michelow; Simon Levin; Mark Faesen; Jennifer S Smith Journal: J Int AIDS Soc Date: 2012-06-07 Impact factor: 5.396
Authors: Sharon A Greene; Hugo De Vuyst; Grace C John-Stewart; Barbra A Richardson; Christine J McGrath; Kara G Marson; T Tony Trinh; Nelly Yatich; Catherine Kiptinness; Anthony Cagle; Evans Nyongesa-Malava; Samah R Sakr; Nelly R Mugo; Michael H Chung Journal: JAMA Date: 2019-10-22 Impact factor: 56.272
Authors: Emmanuel A Oga; Jessica P Brown; Clayton Brown; Eileen Dareng; Victor Adekanmbi; Michael Odutola; Olayinka Olaniyan; Richard Offiong; Kayode Obende; Ayodele Stephen Adewole; Achara Peter; Patrick Dakum; Clement Adebamowo Journal: BMC Womens Health Date: 2016-05-11 Impact factor: 2.809